{"id":"https://openalex.org/W4297130732","doi":"https://doi.org/10.1017/ash.2022.297","title":"Limited impact of a nudge comment in promoting de-escalation to first-generation cephalosporins in urinary tract infections","display_name":"Limited impact of a nudge comment in promoting de-escalation to first-generation cephalosporins in urinary tract infections","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4297130732","doi":"https://doi.org/10.1017/ash.2022.297","pmid":"https://pubmed.ncbi.nlm.nih.gov/36483358","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9726566"},"language":"en","primary_location":{"id":"doi:10.1017/ash.2022.297","doi":"https://doi.org/10.1017/ash.2022.297","is_oa":true,"landing_page_url":"https://doi.org/10.1017/ash.2022.297","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1B31CFE57E5C50BA2E016412E93E151D/S2732494X22002972a.pdf/div-class-title-limited-impact-of-a-nudge-comment-in-promoting-de-escalation-to-first-generation-cephalosporins-in-urinary-tract-infections-div.pdf","source":{"id":"https://openalex.org/S4210182445","display_name":"Antimicrobial Stewardship & Healthcare Epidemiology","issn_l":"2732-494X","issn":["2732-494X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Stewardship & Healthcare Epidemiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1B31CFE57E5C50BA2E016412E93E151D/S2732494X22002972a.pdf/div-class-title-limited-impact-of-a-nudge-comment-in-promoting-de-escalation-to-first-generation-cephalosporins-in-urinary-tract-infections-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014866757","display_name":"Martin T. Brenneman","orcid":"https://orcid.org/0000-0001-9515-7139","observed_orcids":["https://orcid.org/0000-0001-9515-7139"]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin T. Brenneman","raw_affiliation_strings":["Pharmacy Department, Norton Healthcare, Louisville, Kentucky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, Norton Healthcare, Louisville, Kentucky","institution_ids":["https://openalex.org/I202709704"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067467064","display_name":"Sarah E Moore","orcid":"https://orcid.org/0000-0002-3382-2735","observed_orcids":["https://orcid.org/0000-0002-3382-2735"]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]},{"id":"https://openalex.org/I4210131212","display_name":"Norton Hospital","ror":"https://ror.org/03jhxhg55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sarah E. Moore","raw_affiliation_strings":["Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky"],"raw_orcid":"https://orcid.org/0000-0002-3382-2735","affiliations":[{"raw_affiliation_string":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky","institution_ids":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025326680","display_name":"Matthew Song","orcid":"https://orcid.org/0000-0001-8634-6421","observed_orcids":["https://orcid.org/0000-0001-8634-6421"]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]},{"id":"https://openalex.org/I4210131212","display_name":"Norton Hospital","ror":"https://ror.org/03jhxhg55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Song","raw_affiliation_strings":["Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky"],"raw_orcid":"https://orcid.org/0000-0001-8634-6421","affiliations":[{"raw_affiliation_string":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky","institution_ids":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051913748","display_name":"Brian C Bohn","orcid":"https://orcid.org/0000-0002-8458-7800","observed_orcids":["https://orcid.org/0000-0002-8458-7800"]},"institutions":[{"id":"https://openalex.org/I1299725459","display_name":"Barnes-Jewish Hospital","ror":"https://ror.org/04wyvkr12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299725459","https://openalex.org/I1328499231"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian C. Bohn","raw_affiliation_strings":["Department of Pharmacy, Barnes-Jewish Hospital, Saint Louis, Missouri"],"raw_orcid":"https://orcid.org/0000-0002-8458-7800","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Barnes-Jewish Hospital, Saint Louis, Missouri","institution_ids":["https://openalex.org/I1299725459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042669072","display_name":"Elena A. Swingler","orcid":"https://orcid.org/0000-0003-4288-955X","observed_orcids":["https://orcid.org/0000-0003-4288-955X"]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]},{"id":"https://openalex.org/I4210131212","display_name":"Norton Hospital","ror":"https://ror.org/03jhxhg55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena A. Swingler","raw_affiliation_strings":["Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky"],"raw_orcid":"https://orcid.org/0000-0003-4288-955X","affiliations":[{"raw_affiliation_string":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky","institution_ids":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056887190","display_name":"Christopher W. Whitman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122240","display_name":"Mobile Infirmary","ror":"https://ror.org/02pwxft54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210122240"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher W. Whitman","raw_affiliation_strings":["Pharmacy Department, Mobile Infirmary Medical Center, Mobile, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, Mobile Infirmary Medical Center, Mobile, Alabama","institution_ids":["https://openalex.org/I4210122240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036974278","display_name":"Alan D. Junkins","orcid":"https://orcid.org/0009-0000-3871-3653","observed_orcids":["https://orcid.org/0009-0000-3871-3653"]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan D. Junkins","raw_affiliation_strings":["Microbiology Department, Norton Healthcare, Louisville, Kentucky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Microbiology Department, Norton Healthcare, Louisville, Kentucky","institution_ids":["https://openalex.org/I202709704"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011917257","display_name":"Ashley M Wilde","orcid":"https://orcid.org/0000-0001-8459-0025","observed_orcids":["https://orcid.org/0000-0001-8459-0025"]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]},{"id":"https://openalex.org/I4210131212","display_name":"Norton Hospital","ror":"https://ror.org/03jhxhg55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley M. Wilde","raw_affiliation_strings":["Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky"],"raw_orcid":"https://orcid.org/0000-0001-8459-0025","affiliations":[{"raw_affiliation_string":"Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky","institution_ids":["https://openalex.org/I202709704","https://openalex.org/I4210131212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5067467064"],"corresponding_institution_ids":["https://openalex.org/I202709704","https://openalex.org/I4210131212"],"apc_list":{"value":2000,"currency":"USD","value_usd":2000},"apc_paid":{"value":2000,"currency":"USD","value_usd":2000},"fwci":0.1262,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.36494315,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"2","issue":"1","first_page":"e160","last_page":"e160"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11000","display_name":"Infection Control in Healthcare","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-de-escalation","display_name":"antibiotic de-escalation","score":0.9359999895095825},{"id":"https://openalex.org/keywords/first-generation-cephalosporins","display_name":"first-generation cephalosporins","score":0.9240000247955322},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.8709999918937683},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.890999972820282},{"id":"https://openalex.org/keywords/klebsiella-pneumoniae","display_name":"Klebsiella pneumoniae","score":1.0},{"id":"https://openalex.org/keywords/proteus-mirabilis","display_name":"Proteus mirabilis","score":1.0},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.5260000228881836},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.6589999794960022},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.6942223310470581},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.5193018317222595},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4452037513256073},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4037071168422699},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1801796555519104},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1376815140247345},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.11238881945610046},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.10185673832893372}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1017/ash.2022.297","doi":"https://doi.org/10.1017/ash.2022.297","is_oa":true,"landing_page_url":"https://doi.org/10.1017/ash.2022.297","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1B31CFE57E5C50BA2E016412E93E151D/S2732494X22002972a.pdf/div-class-title-limited-impact-of-a-nudge-comment-in-promoting-de-escalation-to-first-generation-cephalosporins-in-urinary-tract-infections-div.pdf","source":{"id":"https://openalex.org/S4210182445","display_name":"Antimicrobial Stewardship & Healthcare Epidemiology","issn_l":"2732-494X","issn":["2732-494X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Stewardship & Healthcare Epidemiology","raw_type":"journal-article"},{"id":"pmid:36483358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36483358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9726566","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9726566/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Steward Healthc Epidemiol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c199a4f2efea445abcf0aca4bae1537a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c199a4f2efea445abcf0aca4bae1537a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1017/ash.2022.297","doi":"https://doi.org/10.1017/ash.2022.297","is_oa":true,"landing_page_url":"https://doi.org/10.1017/ash.2022.297","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1B31CFE57E5C50BA2E016412E93E151D/S2732494X22002972a.pdf/div-class-title-limited-impact-of-a-nudge-comment-in-promoting-de-escalation-to-first-generation-cephalosporins-in-urinary-tract-infections-div.pdf","source":{"id":"https://openalex.org/S4210182445","display_name":"Antimicrobial Stewardship & Healthcare Epidemiology","issn_l":"2732-494X","issn":["2732-494X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Stewardship & Healthcare Epidemiology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4297130732.pdf","grobid_xml":"https://content.openalex.org/works/W4297130732.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2509406828","https://openalex.org/W2805606473","https://openalex.org/W2812583648","https://openalex.org/W2926592097","https://openalex.org/W2988262858","https://openalex.org/W3039726712","https://openalex.org/W3154976971"],"related_works":["https://openalex.org/W2812583648","https://openalex.org/W7165845856","https://openalex.org/W2025022284","https://openalex.org/W6990982504","https://openalex.org/W2150904343","https://openalex.org/W4414331345","https://openalex.org/W4311552016","https://openalex.org/W2212018696","https://openalex.org/W2331309077","https://openalex.org/W4389029948"],"abstract_inverted_index":{"Abstract":[0],"In":[1],"this":[2],"study,":[3],"we":[4],"evaluated":[5],"the":[6],"impact":[7],"of":[8],"a":[9],"microbiology":[10],"nudge":[11],"on":[12],"de-escalation":[13],"to":[14,25,45],"first-generation":[15],"cephalosporins":[16],"in":[17],"hospitalized":[18],"patients":[19],"with":[20,36],"urinary":[21],"tract":[22],"infections":[23],"secondary":[24],"Escherichia":[26],"coli":[27],",":[28,31],"Klebsiella":[29],"pneumoniae":[30],"and":[32],"Proteus":[33],"mirabilis":[34],"isolates":[35],"minimum":[37],"inhibitory":[38],"concentrations":[39],"(MICs)":[40],"\u2264":[41],"16":[42],"\u00b5g/mL.":[43,54],"De-escalation":[44],"first":[46],"generation-cephalosporins":[47],"was":[48],"uncommon":[49],"at":[50],"MICs":[51],"=":[52],"4\u201316":[53]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-09-27T00:00:00"}